
Science Resources RSS Feeds
|
 |
 |
 |
Implanted defibrillators: New recommendations for drivers with ICDs
June 22, 2009
Patients with an Implantable Cardioverter Defibrillator (ICD) have an ongoing risk of sudden incapacitation that might cause harm to others while driving a car. Driving restrictions are imposed making these recommendations an important guideline for patients. A consensus statement with recommendations for drivers with ICD's was presented at a press conference at the Europace 2009 meeting, in Berlin, Germany on Sunday 21 June.
A team of twelve experts from the European Heart Rhythm Association (EHRA), the Council on Cardiovascular Nursing and Allied Professions in ESC (CCNAP) and the Section Cardiac Rehabilitation of the European Association of Cardiovascular Prevention and Rehabilitation, reviewed the literature, assessed the risk and issued a consensus statement.
"Driving restrictions vary across different countries in Europe. We hope the document may serve as an instrument for European and National regulatory authorities to formulate uniform driving regulations", explained Johan Vijgen, chairperson of the task force*.
"Driving restrictions are perceived as difficult for patients and their family and have an immediate consequence for their lifestyle. In addition to the psychological and societal impact, the driving ban may also pose a considerable impact on employment and education and thereby economic status", said Vijgen.
The document presents recommendations for private driving (group 1) and professional driving (group 2). Definitions of the European Council Directives (80/1263/EEC) and (91/439/EEC) are used.
* Group 1: drivers of ordinary motor cycles, cars, and other small vehicles with or without a trailer. * Group 2: drivers of vehicles over 3.5 metric tonnes or passenger carrying vehicles exceeding eight seats excluding the driver.
Since the introduction of the ICD in the early 1980s, multiple trials have demonstrated the efficacy of ICDs for the prevention of sudden arrhythmic death. This resulted in a significant increase in the number of implants. In Western Europe alone, 63000 ICDs were implanted in 2006 and 85500 ICDs in 2008.
Many patients are currently implanted for primary prevention (treatment of patients at risk for life-threatening arrhythmias who have never had sustained ventricular arrhythmias). The risk for sudden incapacitation is lower in these patients. Therefore, driving restriction should be less strict for these patients, than for patients implanted for secondary prevention (those who have survived a life-threatening arrhythmia).
"Patients and their families should receive adequate discharge education and standardized information on driving recommendations. This should result in a better adherence to the recommendations. It should be emphasized that the risk is mainly a consequence of the underlying condition and not of the presence of the ICD", explained Prof Vijgen.
The consensus statement will be published in the June issue of Europace, the official journal of the European Heart Rhythm Association.
*Members of the task force include Johan Vijgen (chairperson) Belgium, Gianluca Botto (Italy) , John Camm (United Kingdom), Carl-Johan Hoijer (Sweden), Werner Jung (Germany), Jean-Yves Le Heuzey (France), Andrzej Lubinski (Poland), Tone M. Norekvål (Norway), Maurizio Santomauro (Italy), Martin Schalij (The Netherlands), Jean-Paul Schmid (Switzerland), and Panos Vardas (Greece)
European Society of Cardiology
|
 |
|
|
ICD cut post-MI deaths by 31%. (Poor Left Ventricular Function).(implanted cardioverter defibrillator)(myocardial infarction)(Brief Article): An article from: Internal Medicine News
by Mitchel L. Zoler (Author)
This digital document is an article from Internal Medicine News, published by International Medical News Group on April 15, 2002. The length of the article is 574 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: ICD cut post-MI deaths by 31%. (Poor Left Ventricular Function).(implanted cardioverter defibrillator)(myocardial infarction)(Brief Article) Author: Mitchel L. Zoler Publication: Internal Medicine News (Magazine/Journal) Date: April 15, 2002 Publisher: International Medical News Group Volume: 35 Issue: 8 Page: 1(2)
Article Type: Brief...
|
|
|
Implanted defibrillators linked to patient deaths and injuries.: An article from: Trial
by Allison Torres Burtka (Author)
This digital document is an article from Trial, published by Thomson Gale on October 1, 2005. The length of the article is 2377 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Implanted defibrillators linked to patient deaths and injuries. Author: Allison Torres Burtka Publication: Trial (Magazine/Journal) Date: October 1, 2005 Publisher: Thomson Gale Volume: 41 Issue: 10 Page: 14(5)
Distributed by Thomson...
|
|
|
Beware of contact dermatitis triggered by ICD implants.(Cardiovacular Medicine)(implanted cardioverter defibrillator): An article from: Family Practice News
by Sherry Boschert (Author)
This digital document is an article from Family Practice News, published by Thomson Gale on April 15, 2006. The length of the article is 634 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Beware of contact dermatitis triggered by ICD implants.(Cardiovacular Medicine)(implanted cardioverter defibrillator) Author: Sherry Boschert Publication: Family Practice News (Magazine/Journal) Date: April 15, 2006 Publisher: Thomson Gale Volume: 36 Issue: 8 Page: 20(1)
Distributed by Thomson...
|
|
|
Nerve conduction studies safe in ICD patients.(Neurology)(implanted cardiac defibrillators): An article from: Internal Medicine News
by Michele G. Sullivan (Author)
This digital document is an article from Internal Medicine News, published by Thomson Gale on December 1, 2006. The length of the article is 620 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Nerve conduction studies safe in ICD patients.(Neurology)(implanted cardiac defibrillators) Author: Michele G. Sullivan Publication: Internal Medicine News (Magazine/Journal) Date: December 1, 2006 Publisher: Thomson Gale Volume: 39 Issue: 23 Page: 19(1)
Distributed by Thomson...
|
|
|
Implanted defibrillator saves lives.(Neighborhood Heart Watch): An article from: Medical Update
by Benjamin Franklin Literary & Medical Society, Inc. (Publisher)
This digital document is an article from Medical Update, published by Benjamin Franklin Literary & Medical Society, Inc. on May 1, 2004. The length of the article is 355 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Implanted defibrillator saves lives.(Neighborhood Heart Watch) Publication: Medical Update (Newsletter) Date: May 1, 2004 Publisher: Benjamin Franklin Literary & Medical Society, Inc. Volume: 29 Issue: 11 Page: 3(2)
Distributed by Thomson...
|
|
|
Electrical storm and implanted defibrillators.(Letters to the Editor)(Letter to the editor): An article from: Southern Medical Journal
by Charles P. Davis (Author)
This digital document is an article from Southern Medical Journal, published by Thomson Gale on May 1, 2007. The length of the article is 904 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Electrical storm and implanted defibrillators.(Letters to the Editor)(Letter to the editor) Author: Charles P. Davis Publication: Southern Medical Journal (Magazine/Journal) Date: May 1, 2007 Publisher: Thomson Gale Volume: 100 Issue: 5 Page: 547(2)
Article Type: Letter to the editor
Distributed by Thomson...
|
|
|
Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators.(Research / Article): ... from: Environmental Health Perspectives
by Douglas W. Dockery (Author), Heike Luttmann-Gibson (Author), David Q. Rich (Author), Mark S. Link (Author), Murray A. Mittleman (Author), Diane R. Gold (Author), Petros Koutrakis (Author), Joel D. Schwartz (Author), Richard L. Verrier (Author)
This digital document is an article from Environmental Health Perspectives, published by National Institute of Environmental Health Sciences on June 1, 2005. The length of the article is 6043 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators.(Research / Article) Author: Douglas W. Dockery Publication: Environmental Health Perspectives (Magazine/Journal) Date: June 1, 2005 Publisher: National Institute of Environmental Health...
|

|
Current Indications for the Implantable Cardioverter Defibrillator (Clinical Approaches To Tachyarrhythmias)
by Dirk Böcker (Author), Lars Eckardt (Author), Gunter Breithardt (Author)
In this book, well-known physicians, Bocker, Eckardt and Breithardt have put together a succinct and focused book that compliments the CATA Series well. Implantation of defibrillators has evolved dramatically since its introduction by Mirowski in 1980. Technological improvements in devices and leads included a gradual reduction in the size of the device, the introduction of the endocardial approach in 1988, the biphasic waveform and antitachycardia pacing in 1991, pectoral implantation in 1995, inclusion of DDD pacing in 1996 and the delivery of atrial therapies in 1998.
Since the first implantation, a huge body of information on the impact of implantable cardioverter defibrillators (ICD) on prognosis has become available, first as observational studies and later as prospective...
|

|
Implantable Defibrillator Therapy: A Clinical Guide (Developments in Cardiovascular Medicine)
by Antonio Pacifico (Author), Philip D. Henry (Author), Gust H. Bardy (Author), Martin Borggrefe (Author), Francis E. Marchlinski (Author), Andrea Natale (Author), Bruce L. Wilkoff (Author)
This textbook on implantable cardioverter defibrillators is organized in five sections: + Indication; + Instrumentation; + Implantation; + Follow-Up; + Complications. Implantable-Cardioverter Defibrillator Therapy: A Clinical Guide, written by leaders in the field, will be a useful resource for cardiac electrophysiologists, general cardiologists and physicians in cardiac electrophysiology training.
|
|
|
Research Frontiers in Implantable Defibrillator Surgery (Medical Intelligence Unit)
by Henry M. Spotnitz (Author)
This text focuses on clinical and laboratory research related to the surgical implantation of defibrillators. Topics covered include patient selection and surgical techniques, anaesthesia techniques, a comparison of results of ICD therapy and standard arrhythmia surgery, techniques for incorporating infection resistance into defibrillators through elutable coatings, implanted defibrillators as a means to protect ambulatory cardiac transplant candidates from lethal arrhythmias, and the impact of defibrillator insertion on systolic and diastolic function of the heart. The book represents the state of the art in clinical experience, clinical trials and clinical and laboratory research in this field.
|
|